T1	HMM 44 69	EFficacy and tolerability
T2	HMM 204 248	low-density lipoprotein cholesterol (LDL-C).
T3	HMM 272 316	high-density lipoprotein cholesterol (HDL-C)
T4	HMM 450 455	LDL-C
T5	HMM 829 856	efficacy and safety profile
T6	HMM 1063 1068	LDL-C
T7	HMM 1283 1368	percent change from baseline in LDL-C and the safety and tolerability of anacetrapib.
T8	HMM 1536 1568	blood pressure and electrolytes.
T9	HMM 1848 1902	Lipid results, clinical CV events, and safety outcomes
